ExpreS2ion’s CEO in interview on 2019 and the company’s new way forward with a stronger pipeline focus
ExpreS2ion Biotech Holding AB (“ExpreS2ion”) publishes an interview with newly appointed CEO Bent Frandsen upon shareholder request. The company’s new way forward with Bent at the helm will include a much stronger focus on building a pipeline portfolio with assets developed in the ExpreS2 platform.The CEO interview is available via this link: https://mailchi.mp/expres2ionbio.com/january2020 This interview is a part of ExpreS[2]ion’s efforts to improve its communication with shareholders and others interested in the company in 2020 and thereafter.